Commerce Bank’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$290K Hold
2,450
﹤0.01% 1173
2026
Q1
$254K Hold
2,450
﹤0.01% 1192
2025
Q4
$256K Hold
2,450
﹤0.01% 1131
2025
Q3
$227K Buy
+2,450
New +$214K ﹤0.01% 1159
2025
Q2
Sell
-2,450
Closed -$212K 1210
2025
Q1
$212K Hold
2,450
﹤0.01% 1125
2024
Q4
$202K Hold
2,450
﹤0.01% 1144
2024
Q3
$213K Hold
2,450
﹤0.01% 1158
2024
Q2
$201K Buy
+2,450
New +$195K ﹤0.01% 1151
2023
Q1
Sell
-5,450
Closed -$428K 1171
2022
Q4
$428K Hold
5,450
﹤0.01% 852
2022
Q3
$389K Buy
+5,450
New +$406K ﹤0.01% 866

Other funds holding PJP

Commerce Bank's PJP Position: Q2 2026 in Review

Commerce Bank held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 2,450 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #1173.

Commerce Bank first reported a position in PJP in Q3 2022 and has held it in 10 quarters since. The position peaked at $428K in Q4 2022. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • Commerce Bank held 2,450 shares of Invesco Pharmaceuticals ETF worth $290K as of Q2 2026.
  • Commerce Bank left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of Commerce Bank's portfolio in Q2 2026, its #1173 holding.
  • Commerce Bank first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and has held it in 10 quarters since.
  • Commerce Bank's Invesco Pharmaceuticals ETF position peaked at $428K in Q4 2022.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Commerce Bank's 13F filing for Q2 2026, filed 12 Aug 2026.